Skip to main content
TORII PHARMACEUTICAL CO., LTD. logo

TORII PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 4551 ISIN · JP3635800000 T Manufacturing
Open in API
Filings indexed 62 across all filing types
Latest filing 2022-08-01 Interim / Quarterly Rep…
Country JP Japan
Listing T 4551

About TORII PHARMACEUTICAL CO., LTD.

https://www.torii.co.jp/en/

Torii Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the development, manufacturing, and marketing of prescription drugs. The company's primary focus is on therapeutic agents for renal diseases and hemodialysis, particularly for chronic kidney disease (CKD). Its portfolio also includes products for skin diseases, HIV, and allergies. Torii Pharmaceutical utilizes strategic partnerships and promotes medical products from its parent company, Japan Tobacco, to provide specialized pharmaceutical solutions.

Recent filings

Filing Released Lang Actions
四半期報告書－第131期第2四半期(令和4年4月1日－令和4年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by Torii Pharmaceutical Co., Ltd. in accordance with the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, management analysis, and auditor review information for the second quarter of the 131st fiscal period (ending June 30, 2022). This fits the definition of an Interim/Quarterly Report (IR). H1 2022
2022-08-01 Japanese
四半期報告書－第131期第1四半期(令和4年1月1日－令和4年3月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by Torii Pharmaceutical Co., Ltd. in accordance with the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, including the balance sheet and income statement for the first quarter of the 131st fiscal period (January 1, 2022, to March 31, 2022). As it provides comprehensive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q1 2022
2022-04-28 Japanese
内部統制報告書－第130期(令和3年1月1日－令和3年12月31日)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act in Japan. It details the company's framework, scope, and results regarding internal controls over financial reporting. This type of document is a standalone audit-related report concerning internal control systems, which falls under the 'Audit Report / Information' category.
2022-03-29 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act of Japan. This specific document type is a mandatory attachment to an Annual Securities Report (Yukashoken Hokokusho) in Japan, where the CEO confirms the accuracy of the report's contents. Since it is a regulatory filing required by law to accompany the annual report but is not the annual report itself, and does not fit into other specific categories like 'Annual Report' or 'Earnings Release', it falls under the 'Regulatory Filings' (RNS) category as a miscellaneous regulatory document. FY 2021
2022-03-29 Japanese
有価証券報告書－第130期(令和3年1月1日－令和3年12月31日)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which translates to 'Annual Securities Report'. This is the standard comprehensive annual financial report required by the Financial Services Agency of Japan under the Financial Instruments and Exchange Act. It contains detailed financial statements, business performance analysis, and corporate information for the fiscal year ending December 31, 2021. This corresponds to the '10-K' category in the provided schema. FY 2021
2022-03-29 Japanese
四半期報告書－第130期第3四半期(令和3年7月1日－令和3年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, including the balance sheet and income statement for the third quarter of the 130th fiscal period (2021). It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-11-01 Japanese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.